Background {#Sec1}
==========

In surgery, post-operative mortality is the most commonly cited outcome variable and to date has been considered the standard measure of quality of care. However, while cardiac operative mortality has fallen (currently 2.1% in the USA ([@CR26]) and 1.5% in the UK (Bridgewater et al. [@CR3])), post-operative morbidity remains common affecting between 4.3% (Fortescue et al. [@CR10]) and 36% (Magovern et al. [@CR21]) of cardiac patients and significantly prolonging length of stay (LOS) (Dupuis et al. [@CR8]). Such morbidity has substantial impact on healthcare resources, with the average in-hospital incremental cost of experiencing any complication at \$15,468 per patient (Brown et al. [@CR4]). Thus, strategies to identify and reduce post-operative morbidity might reduce both patient well-being and healthcare costs.

However, few countries reliably record morbidity outcome data (Weiser et al. [@CR29]). Previously, morbidity definitions included death (Fortescue et al. [@CR10]), focused on major morbid events only (Huijskes et al. [@CR15]), or used surrogate markers of morbidity (for example post-operative LOS (Magovern et al. [@CR21]; Dupuis et al. [@CR8])). Likewise, many national cardiac surgical registers collect only 30-day mortality outcome and in some cases hospital LOS. Contrastingly, although the Society of Thoracic Surgeons national database contains 49 variables related to post-operative events, a composite metric aimed at defining post-operative morbidity includes in-hospital death and only five severe specific morbidities (Shahian et al. [@CR25]).

The Cardiac Post-Operative Morbidity Score (C-POMS) (Sanders et al. [@CR23]) is a simple, validated score (0--13) by which to identify and quantify total morbidity burden (TMB) after adult cardiac surgery (Table [1](#Tab1){ref-type="table"}) on multiple post-operative days. We have previously reported that every unit increase in C-POMS is associated with a 1.7, 2.2 and 4.5-day increase in subsequent LOS on days 3 (D3), 5 (D5) and 8 (D8) (Sanders et al. [@CR23]), which has significant associated health-care costs, organisational and resource implications. Efforts to identify the risk factors associated with this post-operative TMB score may not only assist in identifying modifiable risk factors for which therapeutic interventions can be implemented to reduce the post-operative risk, but also serve to potentially further validate C-POMS as a useful clinical tool in cardiac surgery post-operative morbidity assessment.Table 1The Cardiac Post-Operative Morbidity Score (C-POMS) (as reported in Sanders et al. [@CR23])Morbidity typeC-POMS criteriaPulmonaryPresence of one or more of the following:\
▪ New requirement for oxygen or respiratory support (including nebuliser therapy or request for chest physiotherapy on or after D5)\
▪ Pleural effusion requiring drainageInfectiousPresence of one or more of the following:\
▪ Currently on antibiotics\
▪ Has had a temperature of \>38 °C in the last 24 h\
▪ Has a white cell count/CRP level requiring in-hospital review or treatmentRenalPresence of one or more of the following:\
▪ Presence of decreased urine output requiring intervention (including IV furosemide)\
▪ Increased serum creatinine (\>30% from pre-operative level)\
▪ Urinary catheter in situ\
▪ New urinary incontinence\
▪ Serum potassium abnormalities requiring treatmentGastrointestinalPresence of one or more of the following:\
▪ Unable to tolerate an enteral diet for any reason including nausea, vomiting and abdominal distension\
▪ Nasogastric tube\
▪ Diagnosis of a gastrointestinal bleed\
▪ DiarrhoeaCardiovascularPresence of one or more of the following:\
▪ The use of inotropic therapy for any cardiovascular cause\
▪ Pacing wires (on or after D5) and/or requiring temporary or new permanent pacing\
▪ Diagnostic tests or therapy within the last 24 h for any of the following: (1) new MI or ischaemia, (2) hypotension (requiring fluid therapy, pharmacological therapy or omission of pharmacological therapy, (3) atrial or ventricular arrhythmias, (4) cardiogenic pulmonary oedema, thrombotic event (requiring anticoagulation), (5) hypertension (pharmacological therapy or omission of pharmacological therapy)NeurologicalNew neurological deficit (including confusion, delirium, coma, lack of coordination, drowsy/slow to wake, poor swallow, blurred vision, sedated, changing loss of consciousness)HaematologicalPresence of one or more of the following:\
▪ Untherapeutic INR requiring pharmacological therapy or omission of pharmacological therapy\
▪ Requirement for any of the following within the last 24 h: packed erythrocytes, platelets, fresh-frozen plasma, or cryoprecipitateWoundPresence of one or more of the following:\
▪ Wound dehiscence requiring surgical exploration or drainage of pus from the operation wound with or without isolation of organisms\
▪ Chest drains\
▪ Wound pain significant enough to require continuing or escalating analgesic interventionPainPostoperative pain significant enough to require parenteral opioids and/or continuing or additional analgesiaEndocrineNew or additional requirements for blood sugar managementElectrolyteElectrolyte (including sodium, urea, phosphate) imbalance requiring oral or intravenous intervention (not including potassium as included in renal category)ReviewRemaining in hospital for further review, investigation and/or procedureAssisted ambulationA new or escalated post-operative requirement for mobility assistance (including wheelchair, crutches, zimmer frame, walking sticks or assistance)*CRP* C-reactive protein, *IV* intravenous, *MI* myocardial infarction, *INR* international normalised ratio, *OPA* out-patient appointment, *OT* occupational therapy

Thus, we sought to identify risk factors associated with post-operative TMB, as assessed by the C-POMS tool, with an aim of identifying potentially modifiable risk factors that could be therapeutic targets to reduce post-operative cardiac surgical morbidity.

Methods {#Sec2}
=======

The National Research Ethics Committee London-Bentham (Chair Professor David Katz) gave ethics permission for this study (protocol amendment 7) on 6 September 2011 (reference 04/Q0502/73). All patients included in this study gave written informed consent to participate.

Participants {#Sec3}
------------

Patients were drawn from the development and validation of the C-POMS study, detailed elsewhere (Sanders et al. [@CR23]). In brief, patients undergoing any form of adult cardiac surgery (excluding cardiac surgery for a congenital heart condition or a cardiomyopathy) between January 2005 and November 2007 at the Heart Hospital, University College London Hospitals NHS Trust, UK, and who gave written informed consent were eligible for inclusion. Excluded were those \<18 years old, undergoing emergency surgery, who were enrolled in clinical intervention trials or who died within 5 days of surgery.

C-POMS {#Sec4}
------

The development and validation of the C-POMS tool and score is detailed elsewhere (Sanders et al. [@CR23]). In brief, The McMaster Framework (Kirshner and Guyatt, [@CR18]; Guyatt et al. [@CR12]) for constructing and assessing health indices for discriminative instruments, comprising item selection, item scaling, item reduction and determination of reliability and validity processes, was used. The C-POMS represents TMB as a summary score (0--13), derived by noting the presence or absence of 13 morbidity domains on days 3 (D3), 5 (D5), 8 (D8) and 15 (D15) after cardiac surgery (Table [1](#Tab1){ref-type="table"}).

Pre- and intra-operative clinical data {#Sec5}
--------------------------------------

A protocol development group, comprising 15 representatives from cardiac nursing, surgery, intensive care and anaesthesia, determined the pre-, intra-, and post-operative variables to be collected prior to commencement of the study. In brief, these included demographic details, past and current medical history, coronary heart disease risk factors, routine biochemistry and haematology measurements, anaesthesia details, operative details and a detailed record of the first 24 h in the intensive care unit. Variables were either obtained from the Society of Cardiothoracic Surgery national database or prospectively from the medical and nursing records by a dedicated, experienced research nurse using a standardised proforma.

Identification and categorisation of potential risk factors {#Sec6}
-----------------------------------------------------------

To identify pre-operative risk prediction models of post-operative morbidity following cardiac surgery, a systematic literature review was conducted using the basic framework for conducting systematic reviews from the Centre for Reviews and Dissemination (Dissemination Centre for Reviews and Dissemination [@CR7]). Three methodological quality filters were utilised. Firstly, the study population was defined as an adult population undergoing any form of cardiac surgery (excluding transplantation and grown-up congenital heart surgery); only methodologies that constructed a pre-operative risk assessment tool were included; valid outcomes were mortality and morbidity. There were no exclusions on the basis of the definition of either outcome. Search terms included cardiac surgery score, cardiac surgery risk score, pre-operative risk; cardiac surgery and risk prediction score; cardiac surgery, coronary artery bypass graft (CABG), surgery morbidity and surgery outcome. In addition to publication databases (the National Centre for Biotechnology Information, Entrez retrieval system and the Web of Science ISI Citation Databases), sources of on-going and recently completed studies (The National Research Register, The Cochrane Library of Systematic Reviews) were also interrogated to identify eligible papers. In total, the abstracts of 1067 papers were scrutinised. Backward and forward citation searches were conducted on all identified eligible papers. Overall, a total of 21 pre-operative risk prediction models were identified.

All pre- and intra-operative variables obtained within the C-POMS study were classified with respect to these models into one of two tiers (results in Additional file [1](#MOESM1){ref-type="media"}): Tier 1 variables were those which had been associated with morbidity risk in three or more separate papers (significant evidence), while tier 2 variables were those identified in one or two papers (some evidence).

Statistical methods {#Sec7}
-------------------

Baseline characteristics are presented as mean ± SD or *n* (%). For the univariate analysis, C-POMS is presented as the median score and compared over categories using the Kruskal-Wallis test. The association of continuous variables with C-POMS was assessed using the Spearman rank correlation. For the multivariate analysis, variables with *p* \< 0.25 on univariate analysis were considered for inclusion into the models and stepwise regression with backwards elimination and a threshold of *p* \< 0.05 was run. Validation of the models was performed by running 1000 bootstrap samples. Variables selected in at least 60% of the bootstrap samples were included in the final model. For the data on all time points combined, the models used were random intercept models with time fitted as a fixed effect.

Results {#Sec8}
=======

Baseline participant characteristics {#Sec9}
------------------------------------

Of 748 potentially eligible patients undergoing cardiac surgery, 520 (69.5%) were screened (due to researcher availability) and 464 (89.2%) consented to participate. Fourteen participants subsequently became ineligible, leaving 450 who completed the study. Six participants declined for their data to be used outside the development of C-POMS.

Table [2](#Tab2){ref-type="table"} summarises participant characteristics. The majority were White British (379, 85.4%), male (351, 79.1%) with a mean age of 66.6 years (range 19--91 years). Most had triple vessel disease (243, 54.7%), a good (\>50%) left ventricular ejection fraction (LVEF) (323, 74.1%) and were of moderate mortality risk (mean EuroSCORE 4.1). The majority had elective surgery (69.6%), using cardiopulmonary bypass (412, 93.4%) and stayed on intensive care unit (ICU) for an average of 2.0 days while remaining in the operating hospital for 9.5 days. The observed in-hospital mortality rate was 1.3%. Overall, 444 (100.0%) were in-patients on D1 and D3, 420 (94.6%) on D5, 178 (40.1%) on D8 and 45 (10.1%) on D15. Subsequent risk factor analysis was only appropriate on D3, D5 and D8 due to low numbers on D15.Table 2Baseline characteristics (*n* = 444). All values *n*(%) unless otherwise statedFrequency/mean ± SDDemographics Age (mean/years)66.6 ± 10.7 Female gender93 (20.9) Ethnicity (White British)379 (85.4)Medical history Renal (dialysis)7 (1.6) History of previous MI148 (33.3) Re-operation18 (4.1)Symptoms NYHA Class  I115 (26.0)  II205 (46.3)  III101 (22.8)  IV22 (5.0)Cardiac risk factors Smoking  Current49 (11.0)  Ex245 (55.2)  Never150 (33.8) Hypertension303 (68.2) Hypercholesteraemia343 (77.4) Diabetes103 (23.2) Body mass index (kg/m^2^)/mean28.5 ± 5.6Examination and investigation LVEF  Good323 (74.1)  Fair90 (20.6)  Poor23 (5.3)Pre-operative risk assessment EuroSCORE4.1 ± 2.8Intra-operative details Operative priority---elective309 (69.6) Operation performed  CABG299 (67.3)  AVR61 (13.7)  MVR10 (2.3)  CABG + AVR36 (8.1)  CABG + MVR0 (0.0)  AVR + MVR3 (0.7)  CABG + AVR + MVR2 (0.5)  Other33 (7.4) Cardiopulmonary bypass used412 (93.4)Outcome Length of ICU stay (mean/days)2.0 ± 3.5 Return to theatre21 (4.8) Total length of hospital stay (mean/days)11.8 ± 11.7

### Tier 1 and 2 analysis {#Sec10}

#### Univariate analysis {#FPar1}

Fifty-six variables were identified in tiers 1 and 2. The incidence of seven (12.5%) pre-operative variables (cardiogenic shock, catheter-induced coronary closure, intra-aortic balloon pump, intubation, permanent pacemaker, immunosuppressant medications and inotropes) was too small for analysis, resulting in 49 variables (23 tier 1; 26 tier 2) for analysis. Thirty-three of the 49 (67.3%) variables previously identified to be associated with post-operative morbidity were found to be associated with C-POMS on at least one post-operative day (Table [3](#Tab3){ref-type="table"}). Of those, 10 variables were associated with C-POMS summary score on 1 day only, on either D3 (smoking, body mass index, urgency of operation, use of cardiopulmonary bypass, total drainage within the first 12 h and D1 inotropes) or D5 (ethnicity, neurological history, pre-operative heart rate and dialysis). No variables were solely predictive of D8 C-POMS summary score. Twenty variables (40.8%) were associated with C-POMS summary score on 2 days, while 3 variables (pre-operative albumin and New York Heart Association (NYHA) class and LVEF) were associated with C-POMS summary score on all days.Table 3Univariate analysis: tier 1 and 2 predictors of C-POMS summary score on D3, D5 and D8VariableD3 (*n* = 441)D5 (*n* = 419)D8 (*n* = 177)Median\
C-POMS/Rho*p*Median\
C-POMS/Rho*p*Median\
C-POMS/Rho*p*Tier 1 variablesDemographicsAge0.1880.0000.1100.0250.1330.078Age quartiles 1 (0--59)2.00.0022.00.0102.00.300 2 (60--68)3.02.03.0 3 (69--74)3.02.04.0 4 (≥75)4.02.53.0Age grp 2 \<652.00.0002.00.0442.50.083 65--743.02.03.0 ≥754.02.53.0Age grp 3 \<703.00.0012.00.4263.00.225 70--793.02.03.0 \>805.02.03.0Gender M3.00.0242.00.0163.00.215 F3.03.02.5Medical historyDiabetes Y4.00.0002.50.0153.00.308 N3.02.03.0Cerebrovascular disease Y4.00.0283.00.0234.00.219 N3.02.03.0Neurological history Y4.00.1033.00.0164.00.553 N3.02.03.0Congestive heart failure Y4.00.0094.00.0254.00.310 N3.02.03.0COPD/lung disease Y4.00.0053.00.0123.00.380 N3.02.03.0Renal disease Y5.00.0645.00.0015.00.025 N3.02.03.0POSSUM ECG Normal3.00.0002.00.0003.00.200 Sinus abnormal5.04.0-- AF4.03.03.0 Any other abnormal5.02.52.0Paced Y5.00.0054.00.0142.50.875 N3.02.03.0Dialysis Y5.50.0737.50.0065.50.064 N3.02.03.0Pre-operative measurementsBody mass index(kg/m^2^)0.1000.0430.0770.1300.0990.206 LVEF Good3.00.0132.00.0113.00.013 Fair3.02.04.0 Poor5.05.04.0Intra-operativeType of surgery CABG3.00.0002.00.0003.00.718 AVR4.03.03.0 MVR5.03.03.5 CABG + AVR4.02.03.0 AVR + MVR3.03.04.5 CABG + MVR + AVR5.05.06.0 Other5.03.03.0Urgency of op Elective3.00.0022.00.0613.00.327 Urgent4.02.03.0Within first 12 hSystolic blood pressure (highest)0.0020.9590.0260.599−0.0890.238Tier 2 variablesDemographicsEthnicity Caucasian3.00.0522.00.0083.00.532 Asian2.01.03.0 Black5.03.03.0 Other2.03.01.0Medical history Smoking Current2.00.0482.00.3953.00.753 Ex3.02.03.0 Never3.02.03.0Family Hx CAD Y3.00.0022.00.0193.00.686 N4.02.03.0Atrial arrhythmia Y4.00.0213.00.0073.00.781 N3.02.03.0Pre-operative measurements Albumin−0.2100.000−0.1440.004−0.1830.019 Haemoglobin−0.2790.000−0.1800.000−0.1430.058 Heart rate0.0900.0580.1790.0000.0800.294 Weight0.0440.3690.0420.3990.1010.186No diseased vessels 04.00.0113.00.0003.00.203 13.02.02.0 23.02.02.0 33.02.03.0NYHA class 12.00.0011.00.0023.00.001 23.02.03.0 34.03.03.0 45.02.55.0CCSC class 03.00.0413.00.0423.00.317 12.02.02.0 23.02.03.0 33.02.03.0 44.02.04.0Cardiomegaly Y5.00.0003.00.0004.00.141 N3.03.03.0 Not stated3.03.03.0Extracardiacarteriopathy Y5.00.0033.00.0044.50.147 N3.02.03.0Current medicationsDiuretic Y4.00.0033.00.0033.00.780 N3.02.03.0Intra-operativeCardiopulmonary bypass Y3.00.0012.00.0723.00.098 N2.01.01.0Within 1st 12 h after surgery Total drainage0.1390.0040.0300.5420.0310.679Post-operative (D1)Heart rhythm Sinus rhythm3.00.0002.00.0023.00.473 Sinus tachycardia2.52.02.5 Sinus bradycardia4.02.04.0 Atrial fibrillation5.03.04.0 Other3.02.03.0Inotropes Y4.00.0043.00.0703.00.923 N3.02.03.0

Overall, 8/23 (34.7%) tier 1 variables and 8/26 (34.7%) tier 2 variables were not associated with C-POMS summary score on any post-operative day (results in Additional file [2](#MOESM2){ref-type="media"}).

#### Multivariate analysis {#FPar2}

Of the 49 variables, 16 (32.7%) were independent risk factors of C-POMS summary score on one or more post-operative days, while no variables were associated with C-POMS outcome on all three post-operative days (Table [4](#Tab4){ref-type="table"}).Table 4Tier 1 and 2 (combined) independent predictors of C-POMS summary scoreVariableD3D5D8Combined over all time pointsEffectB(se)*p*EffectB(se)*p*EffectB(se)*p*B(se)*p*Pre-operative haemoglobin1 SD increase−0.42 (0.11)\<0.0001−0.29 (0.12)0.0112-h total drainage1 SD increase0.47 (0.10)\<0.0010.35 (0.10)0.0010.31 (0.09)0.001Pre-operative weight1 SD increase0.34 (0.10)0.0010.27 (0.11)0.020.26 (0.09)0.004Extra-cardiac arteriopathyYes: no0.73 (0.34)0.030.87 (0.35)0.010.66 (0.31)0.03AgePer year0.03 (0.009)0.0010.024 (0.009)DiabetesYes: no0.75 (0.23)0.0020.64 (0.27)0.020.92 (0.22)\<0.0001Left ventricular ejection fractionPoor: good/fair0.88 (0.43)0.041.38 (0.45)0.003CABG surgeryYes: no−1.17 (0.24)\<0.0001−1.02 (0.25)\<0.0001−1.06 (0.21)\<0.0001MVR surgeryYes: no1.40 (0.54)0.01Operative urgencyUrgent: elective0.48 (0.22)0.03Chronic obstructive pulmonary diseaseYes: no0.77 (0.30)0.01NYHA class1 category increase0.47 (0.24)0.05RenalYes: no2.46 (0.74)0.001Pre-operative cardiomegalyYes: no0.66 (0.32)0.040.66 (0.28)0.02Pre-operative albumin1 SD increase−0.43 (0.20)0.04−0.38 (0.09)\<0.0001Number of diseased vesselsIncrease of 11.04 (0.36)0.005Number of saphenous vein grafts1 SD increase−0.66 (0.31)0.04

There were eight tier 1 variables, all of which (with the exception of renal dysfunction) were associated with TMB on D3. Diabetes, LVEF, CABG surgery and renal dysfunction were also associated with D5 C-POMS summary score. However, only tier 2 variables (pre-operative albumin, number of diseased vessels and number of saphenous vein grafts) were independently predictive of D8 score and these variables were not independent risk factors for any other post-operative day. Pre-operative haemoglobin, 12 h drainage, pre-operative weight and extra cardiacarteriopathy were tier 2 risk factors associated with D3 and D5 morbidity score, while pre-operative cardiomegaly and NYHA class were associated with D5 score only. Considering all time points, 12-h total drainage, pre-operative weight, extra-cardiac arteriopathy, age, diabetes, CABG surgery, pre-operative cardiomegaly and pre-operative albumin level were independently predictive of C-POMS-defined post-operative morbidity outcome.

Discussion {#Sec11}
==========

We found that over two thirds (67.3%) of variables, previously reported as a risk factor for post-operative morbidity, were associated with the new C-POMS (denoting TMB) on at least one post-operative day, with 40% being significant risk factors for two post-operative days and three (6.1%) associated on all three post-operative days. From these results, there are four main findings of note. Firstly, we aimed to identify independent modifiable C-POMS risk factors amenable to therapeutic intervention. These were found to be pre-operative albumin and haemoglobin levels and weight---all tier 2 variables. Previously, pre-operative hypoalbuminaemia has been identified as a risk factor for post-operative delirium (Rudolph et al. [@CR22]), reoperation for bleeding (Engelman et al. [@CR9]), requirement for renal replacement therapy need (Engelman et al. [@CR9]; Sato et al. [@CR24]), increased ICU and hospital LOS (Engelman et al. [@CR9]; Koertzen et al. [@CR19]) and increased mortality (Engelman et al. [@CR9]; Koertzen et al. [@CR19]) cardiac surgery. While hypoalbuminaemia may be directly harmful, it may also mark other pathological states, such as anaemia, since pre-operative hypoalbuminaemia and anaemia are independently associated (Carrascal et al. [@CR5]). Similarly, in cardiac surgery, pre-operative anaemia is associated with in-hospital (De Santo et al. [@CR6]; Hung et al. [@CR16]) or 30-day (Boening et al. [@CR2]) mortality, post-operative blood transfusion rate (De Santo et al. [@CR6]; Hung et al. [@CR16]; Boening et al. [@CR2]), ICU (De Santo et al. [@CR6]; Hung et al. [@CR16]) and in-hospital LOS (De Santo et al. [@CR6]), major adverse cardiovascular events (Boening et al. [@CR2]), and renal complications (De Santo et al. [@CR6]; Boening et al. [@CR2]) than non-anaemic patients. However, evidence relating to whether pre-operative anaemia is associated with infection (Boening et al. [@CR2]) or not (De Santo et al. [@CR6]) is conflicting. There is less evidence relating pre-operative weight to post-operative outcome. Weight loss after bariatric surgery improves hypertension, diabetes and dyslipidaemia (Batsis et al. [@CR1]), although unintended pre-operative weight loss (≥10%) is also associated with prolonged hospital LOS (van Venrooij et al. [@CR28]). Evidence of association is, of course, not the same as proof of causation. However, overall, taken with associated literature, our findings suggest pre-operative albumin, haemoglobin and weight to be candidates for pre-operative interventional studies with the aim of improving post-operative morbidity.

Secondly, we identified 17 *independent* risk factors for TMB on at least one post-operative day. Interestingly, except for renal dysfunction, the other seven tier 1 variables were all associated with D3 morbidity, with only three (diabetes, LVEF and CABG surgery) also being associated on D5 and none with D8 morbidity. Independent risk factors for D8 TMB lay entirely in tier 2. Such findings perhaps suggest that different risk factors are associated with outcome on different post-operative days and that well-accepted risk factors may only be useful for predicting morbidity risk in the first few days of recovery. Patterns of morbidity are well-recognised to differ with time after surgery, and it is likely that their drivers (whether they be intrinsic, environmental, or related to nascent morbidities) will also vary. Such factors are likely to explain the fact that correlations between D3 and D5 with D8 data differed. Furthermore, this study adds to the evidence that pre-operative haemoglobin concentration, pre-operative weight, extra-cardiac arteriopathy, pre-operative cardiomegaly, NYHA class, pre-operative albumin, number of diseased vessels, and number of saphenous vein grafts are independently associated with morbidity outcome.

Thirdly, as expected, the majority of tier 1 variables (those with significant evidence of association with post-operative morbidity) were associated with TMB on at least one post-operative day. While this is not clinically surprising, it does further validate C-POMS as a useful clinical tool in outcome assessment following cardiac surgery. In relation to the eight tier 1 variables that were not associated with TMB on any post-operative day, combining cerebrovascular accident and transient ischaemic attack to a combined cerebrovascular disease variable was associated with a higher C-POMS on D3 and D5, in line with other morbidity risk assessment models (Magovern et al. [@CR21]; Huijskes et al. [@CR15]; Higgins et al. [@CR14]; Tuman et al. [@CR27])^.^ Furthermore, while hypertension has been independently associated with post-operative morbidity in some studies (for example, Fortescue et al. ([@CR10]) and Ivanov et al. ([@CR17])), this has been disputed by others (Higgins et al. [@CR14]; Hattler et al. [@CR13]). However, our results pertaining to systolic blood pressure, previous cardiac surgery and diagnosed peripheral vascular disease are at odds with the literature.

Finally, this study also adds to the more limited data relating to some variables (those in tier 2) and their association with post-operative morbidity after cardiac surgery. Of these, 65.4% were associated with C-POMS TMB score on at least one post-operative day, while pre-operative albumin measurement and NYHA class were risk factors for all three post-operative days. Furthermore, this study also confirmed the findings of previous studies suggesting that unstable angina or recent myocardial infarction (Tuman et al. [@CR27]; Hattler et al. [@CR13]) and pre-existing liver disease (Higgins et al. [@CR14]) are not associated with post-operative morbidity. However, while our study corroborated that of Magovern et al. (Magovern et al. [@CR21]) showing that pre-operative atrial arrhythmia and cardiomegaly are associated with morbidity outcome (Magovern et al. [@CR21]), such results conflict with those found by Hattler and colleagues (Hattler et al. [@CR13]).

There are four main limitations of this study. Firstly, there was no consistent definition of post-operative morbidity used in the pre-operative risk assessment models reported by others. Thus, a wide-range of variables to predict such diversely described outcomes were identified. However, over two-thirds of all variables were found to be associated with TMB, as defined by C-POMS, on at least one post-operative day suggesting that C-POMS is a valid measure of morbidity. Secondly, from the pre-operative risk assessment models, it is difficult to assess what variables were not found to be associated with post-operative morbidity. Most studies did not report variables for which no association with morbidity was identified, due to the often large number (\>100) of variables included. We have made our statistically non-significant results available to redress this balance and to aid in the evaluation of this (and other) tools. Thirdly, 14 risk factors identified in the pre-operative risk assessment models were available within this study dataset. Some variables, such as transplantation and ventricular-septal defect, were not available as these surgery types were not included in the study, while the others were non-routinely recorded items. Aside from catastrophic states, the variables not included were all tier 2 variables and in the main were only associated with outcome in one previous study. Finally, analysis to identify risk predictors for C-POMS TMB on D15 could not be conducted due to there being too few participants remaining in the hospital on D15 (*n* = 45). However, this could be the subject of future work.

Conclusions {#Sec12}
===========

Post-operative morbidity is increasingly accepted as an independent quality of care indicator, with approximately 80% of patients wanting to be informed of all the risks associated with surgery (Larobina et al. [@CR20]). Thus, in obtaining operative consent, patients should be told about 'less serious side effects and complications' (General Medical Council [@CR11]). C-POMS is a tool that permits such morbidity assessment and TMB scoring at several time points after cardiac surgery, allowing both broad and detailed tracking of morbidities. We have found that pre-operative albumin, haemoglobin and weight are potentially modifiable risk factors for which the investigation of the effect of therapeutic interventions on C-POMS outcome is warranted. Furthermore, we have identified, for the first time, that risk factors differ for different post-operative days. Further work should include the identification of novel risk factors of C-POMS TMB score for each post-operative day, and the identification of risk factors associated with each C-POMS morbidity type to identify the risk factors associated with D15 C-POMS summary score. Additionally, further validation of these results could be sought in a subsequent C-POMS dataset. Such identification of risk factors for C-POMS TMB may aid patient group and individual risk stratification and potentially reduce healthcare costs.

Additional files {#Sec13}
================

Additional file 1:Variables included in pre-operative prediction models of post-operative morbidity. (DOCX 241 kb) Additional file 2:Univariate analysis: tier 1 and 2 not predictive of C-POMS summary score on D3, D5 and D8. (DOCX 20 kb)

AVR

:   Aortic valve replacement

CABG

:   Coronary artery bypass graft

CAD

:   Coronary artery disease

CCSC

:   Canadian cardiovascular score

COPD

:   Chronic obstructive pulmonary disease

C-POMS

:   Cardiac Post-Operative Morbidity Score

CRP

:   C-reactive protein

D3 (D5, D8, D15),

:   Day 3, (day 5, day 8, day 15)

ICU

:   Intensive care unit

INR

:   International normalised ratio

IV

:   Intravenous

LOS

:   Length of stay

LVEF

:   Left ventricular ejection fraction

MI

:   Myocardial infarction

MVR

:   Mitral valve replacement

NYHA

:   New York Heart Association

OPA

:   Out-patient appointment

OT

:   Occupational therapy

TMB

:   Total morbidity burden

UK

:   United Kingdom

USA

:   United States of America
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